Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- mycophenolic acid
Interactions between your drugs
mycophenolic acid meningococcal group ACWY conjugate-group B vaccine (cvx 316)
Applies to: mycophenolic acid, meningococcal group acwy conjugate-group b vaccine (cvx 316)
If you are currently being treated or have recently been treated with mycophenolic acid, you should let your doctor know before receiving meningococcal group ACWY conjugate-group B vaccine (cvx 316). Depending on the dose and length of time you have been on mycophenolic acid, you may have a reduced response to the vaccine. In some situations, your doctor may want to delay vaccination to give your body time to recover from the effects of mycophenolic acid therapy. If you have recently been vaccinated with meningococcal group ACWY conjugate-group B vaccine (cvx 316), your doctor may choose to postpone treatment with mycophenolic acid for a couple of weeks or more. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food interactions
mycophenolic acid food
Applies to: mycophenolic acid
Take mycophenolic acid on an empty stomach 1 hour before or 2 hours after a meal unless otherwise directed by your doctor. Food may reduce the absorption of mycophenolic acid. This will make it easier for your body to absorb the medication. Do not crush, chew, or cut the tablets. The tablets have a special coating to protect the stomach from irritation.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Cipro
Cipro (ciprofloxacin) is a fluoroquinolone antibiotic used to treat bacterial infections. Learn ...
Rocephin
Rocephin (ceftriaxone) is used to treat bacterial infections, including severe or life-threatening ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Rifadin
Rifadin is used for bartonellosis, endocarditis, haemophilus influenzae prophylaxis, legionella ...
Menveo
Menveo (meningococcal conjugate vaccine) is used to prevent infection caused by meningococcal ...
Trumenba
Trumenba is used for meningitis, meningococcal, meningococcal disease prophylaxis
Menactra
Menactra is used to prevent infection caused by meningococcal bacteria. Learn about side effects ...
Bexsero
Bexsero is used for meningitis, meningococcal, meningococcal disease prophylaxis
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.